Explore. Learn. Join the conversation.

Working Group on New TB Drugs

Stop TB Partnership

PIPELINE > BIOLOGICS

IVIy
Last Updated: 10-Jan-2012


Product Profile

Potential Available, scalable, expensive

  Therapeutic Goal shortening time to sputum clearance
Potential Biomarkers

  Initial Target Population Drug-sensitive

Concerns and Recommendations

Toxicity Known safety profile

  Next Step Phase IIa in TB patients

Additional Description Funding for trials in TB patients. No TB patient experience.

Administration and Handling

Dose Route Schedules Cold Chain Storage
2 g/kg Single Cycle over 2 or 3 days Varies >1yr at +4 0C and 3 months

Related Links